Index by Author

April 2011; 11 (2)
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

A

  1. Afeltra, Antonella

    • Matters of the Heart: The Case of TNFα-Targeting Drugs Mol Interv April 2011 11:79-87; doi:10.1124/mi.11.2.4

  2. Anderson, Rebecca J.

    • Florence Nightingale: The Biostatistician Mol Interv April 2011 11:63-71; doi:10.1124/mi.11.2.1
    • Lady Mildmay’s Modern Medical Cures Mol Interv April 2011 11:72-78; doi:10.1124/mi.11.2.2

  3. Andriantsitohaina, Ramaroson

    • Microvesicles: Intercellular Vectors of Biological Messages Mol Interv April 2011 11:88-94; doi:10.1124/mi.11.2.5

C

  1. Cacciapaglia, Fabio

    • Matters of the Heart: The Case of TNFα-Targeting Drugs Mol Interv April 2011 11:79-87; doi:10.1124/mi.11.2.4

  2. Choi, Jaehwa

    • New Therapeutic Approaches to Combat Arterial Thrombosis: Better Drugs for Old Targets, Novel Targets, and Future Prospects Mol Interv April 2011 11:111-123; doi:10.1124/mi.11.2.9

  3. Czobor, Pál

    • The Secrets of a Successful Clinical Trial: Compliance, Compliance, and Compliance Mol Interv April 2011 11:107-110; doi:10.1124/mi.11.2.8

D

  1. Dai, Yun

    • CHK1 Inhibitors in Combination Chemotherapy: Thinking Beyond the Cell Cycle Mol Interv April 2011 11:133-140; doi:10.1124/mi.11.2.11

  2. Dent, Paul

    • CHK1 Inhibitors in Combination Chemotherapy: Thinking Beyond the Cell Cycle Mol Interv April 2011 11:133-140; doi:10.1124/mi.11.2.11

F

  1. Fisher, Paul B.

    • CHK1 Inhibitors in Combination Chemotherapy: Thinking Beyond the Cell Cycle Mol Interv April 2011 11:133-140; doi:10.1124/mi.11.2.11

G

  1. Grant, Steven

    • CHK1 Inhibitors in Combination Chemotherapy: Thinking Beyond the Cell Cycle Mol Interv April 2011 11:133-140; doi:10.1124/mi.11.2.11

H

  1. Huggins, Gordon S.

    • Mind the dbGAP: The Application of Data Mining to Identify Biological Mechanisms Mol Interv April 2011 11:95-102; doi:10.1124/mi.11.2.6

J

  1. Jelacic, Tanya

K

  1. Kelly, Edward J.

    • Finding Homes for Orphan Cytochrome P450s: CYP4V2 and CYP4F22 in Disease States Mol Interv April 2011 11:124-132; doi:10.1124/mi.11.2.10

  2. Kermode, John C.

    • New Therapeutic Approaches to Combat Arterial Thrombosis: Better Drugs for Old Targets, Novel Targets, and Future Prospects Mol Interv April 2011 11:111-123; doi:10.1124/mi.11.2.9

L

  1. Lazo, John S.

    • Molecular Interventions (2001–2011): An Experiment Completed Mol Interv April 2011 11:62; doi:10.1124/mi.11.2.0

  2. Leonetti, Daniela

    • Microvesicles: Intercellular Vectors of Biological Messages Mol Interv April 2011 11:88-94; doi:10.1124/mi.11.2.5

M

  1. Martínez, M. Carmen

    • Microvesicles: Intercellular Vectors of Biological Messages Mol Interv April 2011 11:88-94; doi:10.1124/mi.11.2.5

  2. Matson, Daniel R.

  3. Menna, Pierantonio

    • Matters of the Heart: The Case of TNFα-Targeting Drugs Mol Interv April 2011 11:79-87; doi:10.1124/mi.11.2.4

  4. Minotti, Giorgio

    • Matters of the Heart: The Case of TNFα-Targeting Drugs Mol Interv April 2011 11:79-87; doi:10.1124/mi.11.2.4

  5. Mullane, Kevin

    • Asthma Therapeutics: Recent Strides, New Hurdles Mol Interv April 2011 11:103-106; doi:10.1124/mi.11.2.7

N

  1. Nakano, Mariko

    • Finding Homes for Orphan Cytochrome P450s: CYP4V2 and CYP4F22 in Disease States Mol Interv April 2011 11:124-132; doi:10.1124/mi.11.2.10

  2. Navarini, Luca

    • Matters of the Heart: The Case of TNFα-Targeting Drugs Mol Interv April 2011 11:79-87; doi:10.1124/mi.11.2.4

R

  1. Rettie, Allan E.

    • Finding Homes for Orphan Cytochrome P450s: CYP4V2 and CYP4F22 in Disease States Mol Interv April 2011 11:124-132; doi:10.1124/mi.11.2.10

  2. Rohatgi, Priyanka

    • Finding Homes for Orphan Cytochrome P450s: CYP4V2 and CYP4F22 in Disease States Mol Interv April 2011 11:124-132; doi:10.1124/mi.11.2.10

S

  1. Salvatorelli, Emanuela

    • Matters of the Heart: The Case of TNFα-Targeting Drugs Mol Interv April 2011 11:79-87; doi:10.1124/mi.11.2.4

  2. Skolnick, Phil

    • The Secrets of a Successful Clinical Trial: Compliance, Compliance, and Compliance Mol Interv April 2011 11:107-110; doi:10.1124/mi.11.2.8

  3. Stukenberg, P. Todd

T

  1. Tang, Yong

    • CHK1 Inhibitors in Combination Chemotherapy: Thinking Beyond the Cell Cycle Mol Interv April 2011 11:133-140; doi:10.1124/mi.11.2.11

  2. Tual-Chalot, Simon

    • Microvesicles: Intercellular Vectors of Biological Messages Mol Interv April 2011 11:88-94; doi:10.1124/mi.11.2.5

W

  1. Wooten, Eric C.

    • Mind the dbGAP: The Application of Data Mining to Identify Biological Mechanisms Mol Interv April 2011 11:95-102; doi:10.1124/mi.11.2.6

Y

  1. Yacoub, Adly

    • CHK1 Inhibitors in Combination Chemotherapy: Thinking Beyond the Cell Cycle Mol Interv April 2011 11:133-140; doi:10.1124/mi.11.2.11

  2. Yarov-Yarovoy, Vladimir

    • Finding Homes for Orphan Cytochrome P450s: CYP4V2 and CYP4F22 in Disease States Mol Interv April 2011 11:124-132; doi:10.1124/mi.11.2.10

Current Issue

  1. April 2011, 11 (2)
  1. Current Issue
  1. Alert me to new issues of MI
Society Logo HighWire Press Logo CLOCKSS logo